Bausch + Lomb ( (BLCO) ) has provided an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
On June 10, 2025, Bausch + Lomb Corporation announced the launch of a €600 million senior secured floating rate notes offering by its subsidiaries, alongside a partial refinancing of its credit agreement. The company plans to use the proceeds to repay existing borrowings and refinance outstanding loans, with the transactions subject to market conditions. The notes will be guaranteed by Bausch + Lomb and secured by first priority liens, though there is no assurance of successful completion.
The most recent analyst rating on (BLCO) stock is a Hold with a $13.38 price target. To see the full list of analyst forecasts on Bausch + Lomb stock, see the BLCO Stock Forecast page.
Spark’s Take on BLCO Stock
According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.
Bausch + Lomb’s overall score reflects solid revenue growth and a strong gross margin, but significant challenges in profitability and cash flow. Technical analysis shows bearish trends, while valuation metrics indicate poor earnings performance. The earnings call provided some optimism with growth in key segments, though risks remain from Pharmaceuticals and tariff pressures.
To see Spark’s full report on BLCO stock, click here.
More about Bausch + Lomb Corporation
Bausch + Lomb ( (BLCO) ) has provided an update.
On June 10, 2025, Bausch + Lomb Corporation announced the launch of a €600 million senior secured floating rate notes offering by its subsidiaries, alongside a partial refinancing of its credit agreement. The company plans to use the proceeds to repay existing borrowings and refinance outstanding loans, with the transactions subject to market conditions. The notes will be guaranteed by Bausch + Lomb and secured by first priority liens, though there is no assurance of successful completion.
The most recent analyst rating on (BLCO) stock is a Hold with a $13.38 price target. To see the full list of analyst forecasts on Bausch + Lomb stock, see the BLCO Stock Forecast page.
Spark’s Take on BLCO Stock
According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.
Bausch + Lomb’s overall score reflects solid revenue growth and a strong gross margin, but significant challenges in profitability and cash flow. Technical analysis shows bearish trends, while valuation metrics indicate poor earnings performance. The earnings call provided some optimism with growth in key segments, though risks remain from Pharmaceuticals and tariff pressures.
To see Spark’s full report on BLCO stock, click here.
More about Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO) is a leading global eye health company that focuses on the development, manufacturing, and marketing of a wide range of products. The company’s core product categories include contact lenses, lens care products, ophthalmic pharmaceuticals, and surgical devices and instruments. Serving both the consumer and the healthcare professional markets, Bausch + Lomb operates in sectors such as Vision Care, Pharmaceuticals, and Surgical, providing solutions aimed at improving vision and overall eye health.
Average Trading Volume: 912.17k
Technical Sentiment Signal: Neutral
Current Market Cap: $4.45B
See more data about BLCO stock on TipRanks’ Stock Overview page.